| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 1 |
| 1 | FLUOROURACIL | 1 |
| 2 | FLUOROURACIL CREAM, 0.5% | 1 |
| 3 | PACLITAXEL | 1 |
| 4 | PACLITAXEL (AIBUMIN-BOUND) | 1 |
| 5 | PEMBROLIZUMAB | 1 |
| 6 | RANIBIZUMAB | 1 |
| 7 | TAGRAXOFUSP | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TAGRAXOFUSP | 1 | 0.0019 |
| 1 | RANIBIZUMAB | 1 | 0.0000 |
| 2 | FLUOROURACIL CREAM, 0.5% | 1 | 0.0000 |
| 3 | FLUOROURACIL | 1 | 0.0000 |
| 4 | PACLITAXEL | 1 | 0.0000 |
| 5 | PEMBROLIZUMAB | 1 | 0.0000 |
| 6 | BEVACIZUMAB | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 2 |
| 1 | CD123 Interaction [EPC] | 1 |
| 2 | Cytotoxin [EPC] | 1 |
| 3 | Microtubule Inhibitor [EPC] | 1 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD123 Interaction [EPC] | 1 | 0.0019 |
| 1 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 2 | 0.0000 |
| 2 | Microtubule Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 1 | 0.0000 |